Obesity (BMI > 30 kg/m2) was present in 58% of AGHD patients and controls, and peak GH levels were inversely associated with BMI in controls (Figure 2C). The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.